期刊文献+

住院患者医院感染临床及病原学结果调查分析 被引量:3

Clinical and etiologic survey on nosocomial infections of inpatients
下载PDF
导出
摘要 目的探讨综合性医院住院患者医院感染的临床特点,以采取相关的有效防治措施。方法采用前瞻性和回顾性结合的调查方法,对我院93680例住院患者的临床资料进行分析,细菌鉴定采用荷兰Organon Teknika公司生产的BarcT/Aiert 240系统检测仪及其配套的成人需氧瓶、小儿需氧瓶;法国生物梅里埃公司生产的api staph和ATB STAPH5试剂条,API 20C AUX酵母菌鉴定系统及ATB-Fungus药敏试验盒。结果医院总例次感染率为3.22%,其中以呼吸道最高,其次为泌尿、皮肤软组织;临床分离的致病菌为革兰氏阴性菌为主,占51.16%;真菌占35.65%;革兰氏阳性菌占13.19%。比较本院2000-2005年医院感染,条件致病菌构成比呈上升趋势。结论医院感染中条件致病菌有增高趋势,加强医院感染管理,积极治疗原发病,减少侵袭性操作,及时病原菌监测,合理使用抗菌药物是降低医院感染的有效措施。 Objective To analyse the clinical feature of nosocomial infections in general hospitals for the purpose of setting up efficient measures against it. Methods An analysis was made on the basis of the survey. The data came from 93680 hospitalized cases from 2000 to 2005. Bacterial identification was conducted with BarcT/Aiert 240 system, api staph and ATB STAPH5 reagent strip, API 20C AUX yeast fungus identifying system as well as ATB-fungus susceptibility test kit. Results The prevalence rate was 3. 22%, in which the main infection site was the upper respiratory tract, and followed by the lower respiratory tract and urinary tract. Among bacteria isolated from clinical cases, 51.16% were G-, 13.19% were G+,and 35.65% were fungi. The proportion of conditional bacteria showed an increasing trend from 2000 to 2005. Conclusion The conditional bacteria show an increasing trend in the nosocomial infections . Strengthening the nosocomial infection management, treating underlying disease actively, minimizing invasive procedures, supervising towards pathogenic bacteria, and using antibacterial drugs rationally are effective strategies to reduce the rate of nosocomial infections.
作者 邓先芳
出处 《西部医学》 2007年第3期402-404,共3页 Medical Journal of West China
关键词 医院感染 感染率 条件致病菌 抗菌药物 Nosomial infections Prevalence rate Conditional bacteria Antibacterial drugs.
  • 相关文献

参考文献7

二级参考文献38

  • 1王宏柏.院内洗手新进展[J].中华医院感染学杂志,2004,14(6):719-720. 被引量:130
  • 2[1]Masuda N,Sakagawa E,Ohya S. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1995, 39(3): 645-649.
  • 3[2]Poole K. Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria[J]. Antimicrob Agents Chemother, 2000, 44(9): 2233-2241.
  • 4[3]Nikaido H. Antibiotic resistance caused by Gram-negative multidrug efflux pumps[J]. Clin Infest Dis, 1998, 27(Suppl 1): S32-S41.
  • 5[4]Srikamar R, Li XZ, Poole K. Inner membrane efflux components are responsible for β-lactam specificity of efflux pumps in Pseudomonas aeruginosa[J]. J Bacteriol, 1997, 179(24): 7875-7881.
  • 6[5]Dekievit TR, Parkins MD, Gillis RJ, et al. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms[J]. Antimicrob Agents Chemother, 2001, 45(6): 1761-1770.
  • 7[6]Masuda N, Sakagawa E, Ohya ST, et al. Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to β-lactam due to reduced expression of the ampC β-lactamase[J].Antimicrob Agents Chemother, 2001, 45(4): 1284-1286.
  • 8[7]Kohler T, Epp SF, Curty LK, et al. Characterization of mexT, the regular of the mex-EmexF-oprN multidrug efflux system of Pseudomonas aeruginosa[J]. J Bacteriol, 1999, 181(20): 6300-6305.
  • 9[8]Zhao Q, Li XZ, Srikumar R,et al. Contribution of outer membrane efflux protein oprM to antibiotic resistance in Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1998, 43(7): 1682-1688.
  • 10[9]Mao W, Warren MS, Lee AO, et al.MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 2001, 45(7): 2001-2007.

共引文献415

同被引文献13

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部